{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T07:40:42Z","timestamp":1708069242688},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.medcli.2016.05.025","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T22:42:03Z","timestamp":1469227323000},"page":"466-467","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concentraciones s\u00e9ricas de glucosa, colesterol y triglic\u00e9ridos en varones con prolactinoma tratados con cabergolina"],"prefix":"10.1016","volume":"147","author":[{"given":"Pedro","family":"Iglesias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Villabona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2016.05.025_bib0030","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"4","author":"Dos Santos Silva","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.medcli.2016.05.025_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of cabergoline on metabolism in prolactinomas","volume":"4","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.medcli.2016.05.025_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000371851","article-title":"Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas","volume":"1","author":"Auriemma","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.medcli.2016.05.025_bib0045","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1210\/jc.2002-021137","article-title":"Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue","volume":"4","author":"Ling","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2016.05.025_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: Response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndr."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316302044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775316302044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T08:55:00Z","timestamp":1536569700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775316302044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0025775316302044"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2016.05.025","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concentraciones s\u00e9ricas de glucosa, colesterol y triglic\u00e9ridos en varones con prolactinoma tratados con cabergolina","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2016.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}